Diagnosis and Management of Resistant Hypertension: A Review

医学 抵抗性高血压 螺内酯 利尿剂 血压 去神经支配 内科学 继发性高血压 心脏病学 重症监护医学 药物治疗 联合疗法
作者
Michel Azizi,Wanpen Vongpatanasin,Naomi D.L. Fisher,Felix Mahfoud,Laurence Amar,Ajay Jayant Kirtane
出处
期刊:JAMA [American Medical Association]
卷期号:335 (16): 1428-1428 被引量:22
标识
DOI:10.1001/jama.2026.1221
摘要

Importance: Hypertension, defined as office systolic blood pressure (SBP) 130 mm Hg or greater and/or diastolic blood pressure 80 mm Hg or greater, affects 43.9% of women and 49.5% of men in the US. Approximately 19.7% of patients treated for hypertension have apparent resistant hypertension (blood pressure ≥130/80 mm Hg) despite using 3 or more antihypertensive medications, preferably a renin-angiotensin system blocker, a calcium channel blocker, and a thiazide-type diuretic, at maximally tolerated doses. Observations: Approximately 10% of patients treated for hypertension have true resistant hypertension confirmed with home or 24-hour ambulatory blood pressure monitoring to exclude white-coat hypertension (approximately 37.5% of apparent resistant hypertension) and after excluding medication nonadherence (approximately 50%) and secondary hypertension such as primary aldosteronism (approximately 5%-25%). Conditions associated with resistant hypertension include obesity, diabetes, chronic kidney disease, and sleep apnea. Resistant hypertension is associated with increased risk of cardiovascular death vs controlled blood pressure at 5 years to 10 years (absolute risk increase, 10.3% [95% CI, 8.7%-12.1%]). Lifestyle modifications for resistant hypertension include a low-sodium diet (<1500 mg/d), reducing or avoiding alcohol, 150 min/wk or more of aerobic exercise, and weight loss. Illicit drugs (eg, cocaine) and medications that increase blood pressure (eg, nonsteroid anti-inflammatory drugs, serotonin-norepinephrine reuptake inhibitors) should be avoided. Sleep apnea should be treated when diagnosis is confirmed. Pharmacologic optimization includes use of combination tablets of antihypertensives; intensifying diuretic therapy by using chlorthalidone; and sequential addition of antihypertensive medications using evidence-based algorithms. In a meta-analysis of 20 studies (9 randomized clinical trials [RCTs] and 11 observational studies [331 participants]), use of antihypertensive therapies that combine 2 to 3 medications into a single formulation reduced SBP by -3.99 mm Hg (95% CI, -7.92 to -0.07) vs equivalent doses given separately. For patients with apparent or true resistant hypertension who have an estimated glomerular filtration rate of 45 mL/min/1.73 m2 or greater and a serum potassium level of 4.5 mmol/L or less, adding spironolactone (25-50 mg/d) compared with placebo lowers office SBP by -13.3 mm Hg (95% CI, -17.89 to -8.72 [4 RCTs]) and 24-hour ambulatory SBP by -8.46 mm Hg (95% CI, -12.54 to -4.38 [2 RCTs]) in a network meta-analysis of 24 RCTs (3485 patients with resistant hypertension). A meta-analysis of 10 RCTs (2478 participants) reported that compared with a sham procedure, catheter-based renal denervation, which disrupts the sympathetic nerves in the renal artery walls, decreased 24-hour ambulatory SBP by -4.4 mm Hg (95% CI, -6.1 to -2.7) and office SBP by -6.6 mm Hg (95% CI, -9.7 to -3.6). Conclusions and Relevance: True resistant hypertension affects 10% of patients treated for hypertension and is diagnosed after excluding white-coat hypertension, medication nonadherence, and secondary hypertension such as primary aldosteronism. First-line treatment includes lifestyle modifications, diuretic therapy with chlorthalidone, and combination tablets of antihypertensives. Spironolactone and renal denervation decrease blood pressure in patients with true resistant hypertension.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zcy完成签到,获得积分10
刚刚
刚刚
SAIKIMORI发布了新的文献求助10
刚刚
zzj发布了新的文献求助10
刚刚
kkk完成签到,获得积分10
1秒前
YY发布了新的文献求助10
1秒前
林夕发布了新的文献求助10
1秒前
嗯嗯嗯嗯发布了新的文献求助10
1秒前
1秒前
CodeCraft的应助被余先生采纳,获得10
1秒前
ZywOo完成签到,获得积分10
2秒前
张文昕关注了科研通微信公众号
2秒前
2秒前
2秒前
Gnaw发布了新的文献求助30
2秒前
3秒前
巫马剑鬼完成签到 ,获得积分10
3秒前
3秒前
小燕尾条完成签到 ,获得积分10
3秒前
3秒前
冰烟发布了新的文献求助30
3秒前
甜美月光完成签到,获得积分10
3秒前
深情安青的应助被阿飞采纳,获得10
4秒前
在水一方的应助被savesunshine1022采纳,获得10
4秒前
喝一杯完成签到,获得积分10
4秒前
5秒前
6秒前
6秒前
星期日不上发条完成签到,获得积分10
6秒前
Yet完成签到,获得积分10
6秒前
6秒前
6秒前
yby110201发布了新的文献求助10
6秒前
7秒前
7秒前
林林完成签到,获得积分10
7秒前
顺利毕业完成签到,获得积分10
7秒前
hahahaweiwei发布了新的文献求助10
7秒前
7秒前
嘻嘻完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8174559
求助须知:如何正确求助?哪些是违规求助? 9566586
关于积分的说明 21787112
捐赠科研通 7768831
什么是DOI,文献DOI怎么找? 3431746
关于科研通互助平台的介绍 2555956
邀请新用户注册赠送积分活动 2477100